Related references
Note: Only part of the references are listed.Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease
D. Yablecovitch et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Syndecans - key regulators of cell signaling and biological functions
Nikolaos A. Afratis et al.
FEBS JOURNAL (2017)
Heparan sulfate and heparin interactions with proteins
Maria C. Z. Meneghetti et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2015)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
Carrie A. Duckworth et al.
ONCOTARGET (2015)
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth
Erik H. Knelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin
Juthamas Ratanavaraporn et al.
ACTA BIOMATERIALIA (2012)
Heparan Sulfate Biosynthesis: Regulation and Variability
Johan Kreuger et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption
Marc Baud'huin et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading
Chandramouli R. Chillakuri et al.
FEBS LETTERS (2010)
Tumor-Derived Syndecan-1 Mediates Distal Cross-Talk with Bone that Enhances Osteoclastogenesis
Thomas Kelly et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
Takako Negishi-Koga et al.
IMMUNOLOGICAL REVIEWS (2009)
Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
DeannaLee M. Beauvais et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin
Shigeyuki Kon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity
Atsushi Irie et al.
BONE (2007)
Skeletal remodeling in health and disease
Mone Zaidi
NATURE MEDICINE (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Syndecans in wound healing, inflammation and vascular biology
Annika N. Alexopoulou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Interactions between heparan sulfate and proteins: the concept of specificity
Johan Kreuger et al.
JOURNAL OF CELL BIOLOGY (2006)
Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells
Constance Y. Fears et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Heparan sulphate proteoglycans:: The sweet side of development
U Häcker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Structural basis for fibroblast growth factor receptor activation
M Mohammadi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Syndecans - New kids on the signaling block
E Tkachenko et al.
CIRCULATION RESEARCH (2005)
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
DR Coombe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Syndecans: Proteoglycan regulators of cell-surface microdomains?
JR Couchman
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin
R Faccio et al.
JOURNAL OF CELL BIOLOGY (2003)
Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells
DM Beauvais et al.
EXPERIMENTAL CELL RESEARCH (2003)
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury
QL Li et al.
CELL (2002)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
Novel drug development opportunities for heparin
R Lever et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis
L Lundin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
